Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
This study describes the radiosynthesis, in vitro and in vivo evaluation of the novel small peptide radioligand, 4-[(18)F]fluorobenzoyl-Phe-Ala-Leu-Gly-Glu-Ala-NH(2,) ([(18)F]FBA-FALGEA-NH(2)) as a positron emission tomography (PET) tracer for imaging of the cancer specific epidermal growth factor receptor (EGFR) variant III mutation, EGFRvIII.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Nuclear Medicine and Biology |
| Vol/bind | 38 |
| Udgave nummer | 4 |
| Sider (fra-til) | 509-515 |
| Antal sider | 7 |
| ISSN | 0969-8051 |
| DOI | |
| Status | Udgivet - 2011 |
ID: 33790946